Ursula Theuretzbacher is a microbiologist and expert for antibacterial drug R&D strategies. Her broad therapeutic area expertise includes antibiotic R&D strategies based on public health needs, public funding strategies for antibacterial R&D, and strategies to improve the use of antibiotics. Previously, she was work package leader or partner in several EU funded international collaborative projects focused on antibacterial drug R&D and reviving of old antibiotics.
Additionally, she served as President of the International Society for Anti-Infective Pharmacology, Founding President of the ESCMID (European Society for Clinical Microbiology and Infectious Diseases) PK/PD of Anti-Infectives Study Group, chairperson of a working group of the International Society of Chemotherapy, and as Executive Committee member of the International Society for Infectious Diseases.
She was member of the coordinating group of the WHO project Priority Pathogen List for R&D and leading scientist for the Clinical Pipeline analysis at WHO. She lectured at the University of Vienna for 10 years and was recently appointed ESCMID Fellow.